CochLear (OTCMKTS:CHEOY) Stock Rating Upgraded by Zacks Research

CochLear (OTCMKTS:CHEOY) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Separately, UBS Group cut CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, CochLear presently has an average rating of “Moderate Buy”.

CochLear Price Performance

CHEOY stock opened at $39.12 on Monday. The company’s 50-day moving average price is $39.27 and its 200 day moving average price is $64.35. CochLear has a 52 week low of $31.82 and a 52 week high of $105.60.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.